Back to Rankings

OABI

OmniAbD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
OABI vs peer average
47/100
OABI vs. peer average (D vs. D)
Grade spread
A 1 · C 2 · D 4 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

ABCL is the first available peer comparator.

AbCellera is the clearest public operating comparator because OmniAb names it as technical competition in both genetically engineered rodent discovery and single-cell screening, making it relevant for platform adoption, partner acquisition and discovery-tool differentiation [#10-K-2026-03-04].

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerABCLAbCellera Biologics
OABI
OmniAb
ABCL
AbCellera Biologics
Grade
D
C
Momentum
87
92
Value
41
41
Sentiment
17
36
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed

Grade position vs ABCL

OABI / ABCL
Grade Position
In line
OABI vs. peer average (D vs. D)
47/100
Momentum
87
ABCL
Value
41
OABI
Sentiment
17
ABCL

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs OABI
1
ABCL
ABCL
C
60/100
-1
2
TWST
TWST
D
40/100
Even
3
FHTX
Foghorn Therapeutics Inc Common
A
100/100
-3
4
TTRX
Turn Therapeutics Inc Common
F
20/100
+1
5
ELDN
Eledon Pharmaceuticals Inc Common
F
20/100
+1
ABCL is the first peer returned for this comparison set.